Mendelian randomization of serum urate and parkinson disease progression.
about
The prediagnostic phase of Parkinson's diseaseSerum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studiesContra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study.Prospective study of plasma urate and risk of Parkinson disease in men and women.Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?Genetically Low Vitamin D Levels, Bone Mineral Density, and Bone Metabolism Markers: a Mendelian Randomisation Study.The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders.Urate Levels Predict Survival in ALS: Analysis of the Expanded PRO-ACT Database.Nature as a Trialist?: Deconstructing the Analogy Between Mendelian Randomization and Randomized Trials.Advances in Biomarker Research in Parkinson's Disease.No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.Urate as a Marker of Risk and Progression of Neurodegenerative Disease.Targeting urate to reduce oxidative stress in Parkinson disease.Low serum uric acid levels in progressive supranuclear palsy.No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity--a Mendelian randomization study.Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain.The significance of uric acid in the diagnosis and treatment of Parkinson disease: An updated systemic review.The Changing Landscape of Parkinson Epidemiologic Research.Genome-wide variant by serum urate interaction in Parkinson's disease.Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson's Disease Models.Potential mechanisms for low uric acid in Parkinson disease.Genome-wide association analysis identifies multiple loci associated with kidney disease-related traits in Korean populations.ALSUntangled No. 37: Inosine*
P2860
Q26768732-399BEE11-6C92-4C99-82F9-8CB8D19AF932Q33770852-822401F1-B5FA-4F76-8919-2D5355A76FAFQ35820242-F649B0CD-DA2F-4ACC-98FD-B610C57028B6Q36580376-CD56B1C9-08BD-4DDB-B311-7A32ECE10C50Q37090660-6F1AA93E-80D2-4DDD-9FB3-796CF53EAEEFQ37254219-F257B217-471A-436B-9C7C-B31C975DFADAQ38522643-9727D36D-9EE7-497A-A998-2899560C5CF8Q38600633-0D76ADE6-7B1F-4961-9CD6-2D6680CAF99AQ38673762-C6F90B61-D02B-49D3-AF09-81D7A90A3820Q38681599-B7B3DD17-6BB7-479A-9C5A-FBF2770CBF8AQ38736768-5BA6BDF3-0A98-45B8-B13B-F4F8BC82E04AQ38748158-648747E9-EB4C-40FD-8A53-FF39245D839EQ39044143-D2024E2C-4C98-423A-B040-BD3539EE8EDAQ39379023-BF287CC5-579B-4CBD-96F8-40E620AA741BQ40190481-B3D37A21-C28A-4BA4-8FCB-87FB5FF8FA05Q40296281-37C315FD-5754-41AB-AB8C-A4195001C6E5Q42247910-921FB441-D170-4A7E-A770-80E173BE5632Q47597895-A434DDF0-E264-454C-80F4-C410B91251C0Q47662113-F2E5F5F0-DD3B-4B6A-A3BA-8712AADD744AQ48075588-A4417C82-CC63-40CD-B9D5-9F850BBAFA54Q49698299-1AC0EC59-9231-42DA-B5A5-E0BB75C3E415Q53328368-33C0EB2A-79AB-4D1B-B69B-D906A943B8E4Q54943914-B95A3ACE-7DF2-413F-BCDE-ED69B56EE69DQ57464278-9091DCCE-A213-4DBE-9C16-0C31D0D5263C
P2860
Mendelian randomization of serum urate and parkinson disease progression.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mendelian randomization of serum urate and parkinson disease progression.
@ast
Mendelian randomization of serum urate and parkinson disease progression.
@en
Mendelian randomization of serum urate and parkinson disease progression.
@nl
type
label
Mendelian randomization of serum urate and parkinson disease progression.
@ast
Mendelian randomization of serum urate and parkinson disease progression.
@en
Mendelian randomization of serum urate and parkinson disease progression.
@nl
prefLabel
Mendelian randomization of serum urate and parkinson disease progression.
@ast
Mendelian randomization of serum urate and parkinson disease progression.
@en
Mendelian randomization of serum urate and parkinson disease progression.
@nl
P2093
P2860
P50
P356
P1433
P1476
Mendelian randomization of serum urate and parkinson disease progression.
@en
P2093
David Oakes
Ira Shoulson
Kelly Claire Simon
Parkinson Study Group
Shirley Eberly
P2860
P304
P356
10.1002/ANA.24281
P577
2014-10-03T00:00:00Z